WallStreetZenWallStreetZen

NASDAQ: CBIO
Crescent Biopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Crescent Biopharma revenue was $0.00 for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CBIO annual revenue was $0.0, with -100% growth year-over-year.

CBIO past revenue growth

How has CBIO's revenue growth performed historically?

Company
-100%
Industry
1,514.97%
Market
36.54%
CBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CBIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CBIO revenue history

Current Revenue
$0.0
Current Earnings
-$29.5M
Current Profit Margin
0%

Be the first to know when CBIO announces revenue.

CBIO Revenue History By Year

CBIO Yearly RevenueCBIO RevenueCBIO ChangeCBIO Revenue Growth
2024-12-31$0.00-$10.00k-100.00%
2023-12-31$10.00k-$65.00k-86.67%
2022-12-31$75.00k-$1.08M-93.53%
2021-12-31$1.16M-$9.00M-88.59%
2020-12-31$10.16MN/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00-$18.50k-100.00%
2016-12-31$18.50k-$20.05M-99.91%
2015-12-31$20.07M$5.04M+33.56%
2014-12-31$15.03M$11.03M+276.37%
2013-12-31$3.99M-$11.26M-73.83%
2012-12-31$15.26M$11.44M+300.04%
2011-12-31$3.81MN/AN/A

1 of 1

Crescent Biopharma Revenue FAQ

What was CBIO's revenue last quarter?

On Invalid Date, Crescent Biopharma (NASDAQ: CBIO) reported Q1 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Crescent Biopharma's revenue was $0.00.

What was Crescent Biopharma's revenue in 2024?

Crescent Biopharma's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.

How much does Crescent Biopharma make in a day?

Based on Crescent Biopharma annual revenue for the past five years, CBIO makes an average of $6,250.80 per day.

What was Crescent Biopharma's annual revenue growth in the past year?

As of Q2 2025, Crescent Biopharma's revenue has grown -100% year over year. This is 1,614.97 percentage points lower than the US Biotechnology industry revenue growth rate of 1,514.97%. Crescent Biopharma's revenue in the past year totaled $0.00.

How much does Crescent Biopharma make in a year?

Crescent Biopharma's revenue by year for the past five years is:
  • Crescent Biopharma's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
  • Crescent Biopharma's annual revenue for Dec 31, 2023 was $10.00 thousand, a 86.67% decrease from 2022.
  • Crescent Biopharma's annual revenue for 2022 was $75.00 thousand, a 93.53% decrease from 2021.
  • Crescent Biopharma's annual revenue for 2021 was $1.16 million, a 88.59% decrease from 2020.
  • Crescent Biopharma's annual revenue for 2020 was $10.16 million, a Infinity% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.